Furthermore, SLC35C1 expression has been previously found to be elevated in lung tumors compared to normal tissues in the TCGA cohort, and was also correlated with the tumor microenvironment and tumor molecular burden, microsatellite instability, and antitumor drug sensitivity in cancer [24]. This evidence concerns the gene SLC35C1 and cancer.